Danqi Fu
State Key Laboratory Of Druggability Evaluation And Systematic Translational Medicine, Tianjin Key Laboratory Of Digestive Cancer
Tianjin, 300060, China
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The c-Myc-USP14-PFKP axis sustains chemoresistance in pancreatic ductal adenocarcinoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: January 27, 2026
Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling.
Journal: Gut
Published: August 16, 2024
BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism.
Journal: Science advances
Published: June 19, 2024
Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 20, 2022
Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma.
Journal: Cell discovery
Published: August 30, 2021
Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma.
Journal: The Journal of experimental medicine
Published: April 23, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026